Pardes Biosciences Price Prediction

PRDSDelisted Stock  USD 2.14  0.01  0.47%   
At this time, The value of RSI of Pardes Biosciences' share price is at 51 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Pardes Biosciences, making its price go up or down.

Oversold Vs Overbought

51

 
Oversold
 
Overbought
The successful prediction of Pardes Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Pardes Biosciences and does not consider all of the tangible or intangible factors available from Pardes Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with Pardes Biosciences, which may create opportunities for some arbitrage if properly timed.
Using Pardes Biosciences hype-based prediction, you can estimate the value of Pardes Biosciences from the perspective of Pardes Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pardes Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Pardes because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Pardes Biosciences after-hype prediction price

    
  USD 2.14  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pardes Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
1.751.752.35
Details
Naive
Forecast
LowNextHigh
2.282.282.28
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.142.152.16
Details

Pardes Biosciences After-Hype Price Prediction Density Analysis

As far as predicting the price of Pardes Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pardes Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pardes Biosciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Pardes Biosciences Estimiated After-Hype Price Volatility

In the context of predicting Pardes Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pardes Biosciences' historical news coverage. Pardes Biosciences' after-hype downside and upside margins for the prediction period are 2.14 and 2.14, respectively. We have considered Pardes Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.14
2.14
After-hype Price
2.14
Upside
Pardes Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Pardes Biosciences is based on 3 months time horizon.

Pardes Biosciences Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Pardes Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pardes Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pardes Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
3 Events / Month
10 Events / Month
In about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.14
2.14
0.00 
0.00  
Notes

Pardes Biosciences Hype Timeline

Pardes Biosciences is at this time traded for 2.14. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pardes is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Pardes Biosciences is about 0.0%, with the expected price after the next announcement by competition of 2.14. About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pardes Biosciences recorded a loss per share of 1.28. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Pardes Biosciences Related Hype Analysis

Having access to credible news sources related to Pardes Biosciences' direct competition is more important than ever and may enhance your ability to predict Pardes Biosciences' future price movements. Getting to know how Pardes Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pardes Biosciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
STTKShattuck Labs(0.01)7 per month 0.00 (0.15) 7.03 (9.82) 52.02 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.18) 6.21 (9.35) 34.87 
CSBRChampions Oncology(0.24)6 per month 3.87 (0.02) 6.23 (6.96) 22.49 
IPSCCentury Therapeutics 0.01 9 per month 0.00 (0.11) 6.21 (8.82) 23.66 
NLTXNeoleukin Therapeutics(0.14)1 per month 0.00 (0.08) 4.05 (3.53) 27.84 
TILInstil Bio(1.77)9 per month 6.84  0.12  20.63 (10.89) 105.83 
ACHLAchilles Therapeutics PLC(0.03)4 per month 1.56  0.12  3.06 (2.88) 38.16 
NXTCNextCure 0.01 5 per month 0.00 (0.12) 5.22 (5.52) 21.68 
ASMBAssembly Biosciences(0.72)7 per month 4.40 (0) 8.49 (5.34) 24.80 
CTMXCytomX Therapeutics(0.01)9 per month 0.00 (0.18) 5.00 (5.49) 20.61 
NUVBNuvation Bio 0.21 8 per month 4.53 (0.01) 9.48 (8.36) 21.30 
OVIDOvid Therapeutics 0.03 7 per month 0.00 (0.05) 5.93 (6.25) 19.20 
CNTBConnect Biopharma Holdings 0.02 5 per month 5.35  0.01  12.12 (9.01) 48.67 

Pardes Biosciences Additional Predictive Modules

Most predictive techniques to examine Pardes price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pardes using various technical indicators. When you analyze Pardes charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Pardes Biosciences Predictive Indicators

The successful prediction of Pardes Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pardes Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pardes Biosciences based on analysis of Pardes Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pardes Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pardes Biosciences's related companies.

Story Coverage note for Pardes Biosciences

The number of cover stories for Pardes Biosciences depends on current market conditions and Pardes Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pardes Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pardes Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Pardes Biosciences Short Properties

Pardes Biosciences' future price predictability will typically decrease when Pardes Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pardes Biosciences often depends not only on the future outlook of the potential Pardes Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pardes Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding58.1 M
Cash And Short Term Investments197.3 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Pardes Stock

If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges